149 related articles for article (PubMed ID: 32683361)
1. Is Adjuvant Therapy Necessary for Patients with Intermediate-Risk Cervical Cancer after Open Radical Hysterectomy?
Yahata H; Sonoda K; Inoue S; Yasutake N; Kodama K; Yagi H; Yasunaga M; Ohgami T; Onoyama I; Kaneki E; Okugawa K; Asanoma K; Kato K
Oncology; 2020; 98(12):853-858. PubMed ID: 32683361
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
3. Radical hysterectomy without adjuvant radiotherapy in patients with cervix carcinoma FIGO 2009 IB1, with or without positive Sedlis criteria.
Haesen J; Salihi R; Van Gorp T; Van Nieuwenhuysen E; Han SN; Christiaens M; Van Rompuy AS; Waumans L; Neven P; Vergote I
Gynecol Oncol; 2021 Sep; 162(3):539-545. PubMed ID: 34253389
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes and prognostic factors of node-negative cervical cancer patients with deep stromal invasion or lymphovascular space involvement following radical hysterectomy.
Suprasert P; Srisomboon J; Siriaunkgul S; Khunamornpong S; Phongnarisorn C; Siriaree S; Charoenkwan K; Cheewakriangkrai C; Kietpeerakool C
J Med Assoc Thai; 2006 Sep; 89(9):1368-75. PubMed ID: 17100371
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and adjuvant therapy on survival in early-stage cervical adenocarcinoma/adenosquamous carcinoma after primary radical surgery: A Taiwanese Gynecologic Oncology Group (TGOG) study.
Twu NF; Ou YC; Liao CI; Chang WY; Yang LY; Tang YH; Chen TC; Chen CH; Chen TH; Yeh LS; Hsu ST; Chen YC; Chang CC; Cheng YM; Huang CY; Liu FS; Lin YS; Hsiao SM; Kan YY; Lai CH
Surg Oncol; 2016 Sep; 25(3):229-35. PubMed ID: 27566027
[TBL] [Abstract][Full Text] [Related]
6. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy.
Ho CM; Chien TY; Huang SH; Wu CJ; Shih BY; Chang SC
Gynecol Oncol; 2004 May; 93(2):458-64. PubMed ID: 15099962
[TBL] [Abstract][Full Text] [Related]
7. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
[TBL] [Abstract][Full Text] [Related]
8. Locoregional spread and survival of stage IIA1 versus stage IIA2 cervical cancer.
Hongladaromp W; Tantipalakorn C; Charoenkwan K; Srisomboon J
Asian Pac J Cancer Prev; 2014; 15(2):887-90. PubMed ID: 24568513
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy versus radiotherapy for FIGO stages IB1 and IIA1 cervical carcinoma patients with postoperative isolated deep stromal invasion: a retrospective study.
Li L; Song X; Liu R; Li N; Zhang Y; Cheng Y; Chao H; Wang L
BMC Cancer; 2016 Jul; 16():403. PubMed ID: 27387204
[TBL] [Abstract][Full Text] [Related]
10. Risk assessment in the patients with uterine cervical cancer harboring intermediate risk factors after radical hysterectomy: a multicenter, retrospective analysis by the Japanese Gynecologic Oncology Group.
Shigeta S; Shimada M; Tsuji K; Nagai T; Tanase Y; Matsuo K; Kamiura S; Iwata T; Yokota H; Mikami M
Int J Clin Oncol; 2022 Sep; 27(9):1507-1515. PubMed ID: 35701640
[TBL] [Abstract][Full Text] [Related]
11. Both TPA and SCC-Ag levels are prognostic even in high-risk stage Ib-IIa cervical carcinoma as determined by a stratification analysis.
Yuan CC; Wang PH; Ng HT; Tsai LC; Juang CM; Chiu LM
Eur J Gynaecol Oncol; 2002; 23(1):17-20. PubMed ID: 11876385
[TBL] [Abstract][Full Text] [Related]
12. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
[TBL] [Abstract][Full Text] [Related]
13. [Comparative analysis of the prognosis of patients with locally advanced cervical cancer undergoing laparoscopic or abdominal surgery].
Xu YP; Wang ZQ; Liang XD; Wang Y; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2020 Sep; 55(9):609-616. PubMed ID: 32957749
[No Abstract] [Full Text] [Related]
14. Feasibility Study of Adjuvant Chemotherapy Using Taxane Plus Carboplatin for High-Risk Patients With Uterine Cervical Non-Squamous Cell Carcinoma After Radical Hysterectomy.
Sato S; Shimada M; Ohta T; Kojimahara T; Tokunaga H; Takano T; Yamaguchi S; Tanabe H; Nishio S; Kigawa J
Int J Gynecol Cancer; 2016 Mar; 26(3):561-7. PubMed ID: 26825829
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study).
Nakamura K; Kitahara Y; Satoh T; Takei Y; Takano M; Nagao S; Sekiguchi I; Suzuki M
World J Surg Oncol; 2016 Jun; 14(1):173. PubMed ID: 27356862
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment of microinvasive cervical cancer: analysis of pathologic features with implications on radicality.
Yoneda JY; Braganca JF; Sarian LO; Borba PP; Conceição JC; Zeferino LC
Int J Gynecol Cancer; 2015 May; 25(4):694-8. PubMed ID: 25742569
[TBL] [Abstract][Full Text] [Related]
18. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
[TBL] [Abstract][Full Text] [Related]
19. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
[TBL] [Abstract][Full Text] [Related]
20. Conization pathologic features as a predictor of intermediate and high risk features on radical hysterectomy specimens in early stage cervical cancer.
Hutchcraft ML; Smith B; McLaughlin EM; Hade EM; Backes FJ; O'Malley DM; Cohn DE; Fowler JM; Copeland LJ; Salani R
Gynecol Oncol; 2019 May; 153(2):255-258. PubMed ID: 30718123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
